RT Book, Section
A1 Ferreira-González, Ignacio
A1 Montori, Victor M.
A1 Busse, Jason W.
A1 Schünemann, Holger J.
A1 Jaeschke, Roman
A1 Deveraux, PJ
A1 Permanyer-Miralda, Gaietà
A1 Guyatt, Gordon
A2 Guyatt, Gordon
A2 Rennie, Drummond
A2 Meade, Maureen O.
A2 Cook, Deborah J.
SR Print(0)
ID 1183876406
T1 Composite End Points
T2 Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-179071-0
LK jamaevidence.mhmedical.com/content.aspx?aid=1183876406
RD 2024/04/19
AB CLINICAL  SCENARIOYou  are  an  internist  seeing  a  65-year-old  man  with  stress  test–documented  angina  who—despite  taking  carefully  titrated  β-blockers,  nitrates,  aspirin,  an  angiotensin-converting  enzyme  (ACE)  inhibitor,  and  a  statin—is  substantially  restricted  in  his  activities.  The  patient  undergoes  coronary  angiography,  which  reveals  3-vessel  severe  coronary  disease.  You  suggest  to  him  the  possibility  of  surgical  revascularization  with  coronary  artery  bypass  grafting  (CABG).  The  patient  expresses  reluctance  to  undergo  such  an  invasive  procedure,  and  he  asks  if  there  is  a  less  aggressive  approach  that  might  be  almost  as  effective.  You  consider  the  possibility  of  a  percutaneous  coronary  intervention  (PCI)  as  an  alternative.